Company Filing History:
6 out of 6 
1 out of 36 
1 out of 46 
Years Active: 2013-2023
Title: Katherine Cohen: Innovator in Vaccine Development
Introduction
Katherine Cohen is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of vaccine development, particularly in the areas of cytomegalovirus (CMV) and human papillomavirus (HPV) vaccines. With a total of 8 patents, her work has the potential to impact public health significantly.
Latest Patents
Cohen's latest patents include innovative approaches to CMV vaccines. These patents describe genetically modified arenaviral vectors that are suitable for the prevention and treatment of cytomegalovirus infections and reactivation. Additionally, her work encompasses pharmaceutical compositions and methods aimed at treating these infections. In the realm of HPV, her patents focus on genetically modified arenaviruses that serve as vaccines against neoplastic diseases or cancer. This includes methods for preventing or treating infections associated with oncogenic viruses, particularly those leading to cervical cancer and other related conditions.
Career Highlights
Throughout her career, Katherine Cohen has worked with notable companies such as Hookipa Biotech GmbH and Intercell AG. Her experience in these organizations has allowed her to advance her research and contribute to the development of groundbreaking vaccine technologies.
Collaborations
Cohen has collaborated with esteemed colleagues, including Klaus Orlinger and Thomas P Monath. These partnerships have further enriched her research and innovation in the field of vaccine development.
Conclusion
Katherine Cohen's contributions to vaccine research and development are noteworthy. Her innovative patents and collaborations highlight her commitment to advancing public health through scientific discovery.